Johnson & Johnson to buy private robotics firm Auris for $3.4 bln

Feb 13 () - Johnson & Johnson is buying privately held surgical robotics company Auris Health Inc for about $3.4 billion in cash, the healthcare conglomerate said on Wednesday, as it continues its push into robotics.

The agreement includes additional payments by J&J of $2.35 billion, contingent upon Auris reaching certain milestones, J&J said, without elaborating.

Auris Health is a developer of robotic technologies focused on lung cancer. The deal follows J&J's acquisition last year of Orthotaxy, a privately held developer of software-enabled surgery technologies.

The acquisition is expected to close by the end of the second quarter of 2019.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.